Austar Lifesciences Limited
AULSF
$0.07
$0.071,300.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.59% | 142.35% | -0.48% | 75.58% | -0.86% |
| Total Depreciation and Amortization | 0.59% | -12.40% | -0.48% | 12.59% | -0.86% |
| Total Amortization of Deferred Charges | 0.61% | -9.42% | -0.50% | 25.33% | -0.84% |
| Total Other Non-Cash Items | -0.59% | -167.22% | -0.47% | 245.57% | 0.86% |
| Change in Net Operating Assets | -- | -- | -0.48% | -- | -- |
| Cash from Operations | 0.59% | -51.38% | -0.48% | 310.36% | -0.86% |
| Capital Expenditure | -0.59% | 25.17% | 0.48% | -170.38% | 0.85% |
| Sale of Property, Plant, and Equipment | -- | -- | 0.49% | -12,062.30% | 0.00% |
| Cash Acquisitions | -- | -- | -0.51% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.60% | -42.32% | -0.48% | -17.12% | -0.85% |
| Cash from Investing | -0.58% | 65.58% | 0.49% | -164.88% | -0.86% |
| Total Debt Issued | 0.00% | -2.48% | 0.00% | 14.33% | 0.00% |
| Total Debt Repaid | 0.00% | 5.00% | 0.00% | -5.69% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 14.63% | 0.00% | 12.69% | 0.00% |
| Cash from Financing | -0.59% | 16.62% | 0.48% | 18.16% | 0.86% |
| Foreign Exchange rate Adjustments | -1.00% | -118.15% | -0.36% | 138.36% | -0.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.61% | -107.90% | -0.49% | 214.09% | 0.86% |